SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen, T Redchuk… - Molecular Systems …, 2021 - embopress.org
Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …
被引用次数：72 相关文章

SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen, T Redchuk… - 2021 - agris.fao.org
Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …
[HTML] embopress.org

[HTML][HTML] SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen, T Redchuk… - Molecular Systems …, 2021 - embopress.org
Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …

SARS-CoV-2-host proteome interactions for antiviral drug discovery.

X Liu, S Huuskonen, T Laitinen, T Redchuk… - Molecular Systems …, 2021 - europepmc.org
Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …

[引用][C] SARS-CoV-2-host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen… - Molecular …, 2021 - tobias-lib.ub.uni-tuebingen.de
SARS-CoV-2-host proteome interactions for antiviral drug discovery SARS-CoV-2-host
proteome interactions for antiviral drug discovery DSpace Repositorium (Manakin basiert) …
[HTML] nih.gov

[HTML][HTML] SARS‐CoV‐2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen, T Redchuk… - Molecular Systems …, 2021 - ncbi.nlm.nih.gov
Abstract Treatment options for COVID‐19, caused by SARS‐CoV‐2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …

SARS-CoV-2-host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen… - Molecular …, 2021 - pubmed.ncbi.nlm.nih.gov
Treatment options for COVID-19, caused by SARS-CoV-2, remain limited. Understanding
viral pathogenesis at the molecular level is critical to develop effective therapy. Some recent …

SARS-CoV-2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Redchuk, K Salokas… - Molecular Systems …, 2021 - elibrary.ru
SARS-CoV-2–host proteome interactions for antiviral drug discovery КОРЗИНА ПОИСК
НАВИГАТОР ЖУРНАЛЫ КНИГИ ПАТЕНТЫ ПОИСК АВТОРЫ ОРГАНИЗАЦИИ КЛЮЧЕВЫЕ …
[PDF] helsinki.fi

[PDF][PDF] SARS-CoV-2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen, T Redchuk… - Molecular Systems …, 2021 - helda.helsinki.fi
Abstract Treatment options for COVID-19, caused by SARS-CoV-2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …
[PDF] researchgate.net

[PDF][PDF] SARS-CoV-2–host proteome interactions for antiviral drug discovery

X Liu, S Huuskonen, T Laitinen… - Molecular Systems …, 2021 - researchgate.net
Abstract Treatment options for COVID-19, caused by SARS-CoV-2, remain limited.
Understanding viral pathogenesis at the molecular level is critical to develop effective …